key articles
Time to recurrence significantly predicts cancer-specific survival in patients with recurrent kidney cancer (CORONA/SATURN Project)
Tuesday, 11 June 2013- Around 20-40% of renal cell carcinoma (RCC) patients will develop recurrence after surgery with curative intention, which will develop within the first five years after primary surgery in most cases,...
Changing prognosis of renal cell carcinoma
Friday, 12 April 2013- P. Charlesworth and colleagues conducted a study to examine renal cancer nephrectomies over 25 years in their centre and the factors underlying changes in disease-specific survival. They published their...
Safety and efficacy of everolimus in Chinese patients with metastatic kidney cancer
Tuesday, 2 April 2013- In China, there are currently no approved therapies for the treatment of metastatic renal cell carcinoma (mRCC) following progression with vascular endothelial growth factor (VEGF)-targeted agents.
In the...
Large study examines aggressive potential of small kidney tumours
Friday, 22 March 2013 – Small kidney tumours have an aggressive potential and should be treated, according to the results of a large multicentre study presented at the recently concluded 28th Annual EAU Congress in Milan.
“Many...
Combination therapy for kidney cancer fails to deliver better results
Thursday, 21 February 2013- Combination therapy for metastatic renal cell carcinoma (RCC) failed to improve outcomes compared with bevacizumab (Avastin) alone and caused more toxicity, results of a randomized trial...
Hereditary papillary RCC primarily diagnosed in a cervical lymph node: a case report
Friday, 18 January 2013- Papillary renal cell carcinoma is a rare cancer. Some cases can be attributed to individuals with hereditary renal cell carcinomas usually consisting of the clear cell subtype. In addition, two syndromes...
US doctors develop more efficient robot-assisted partial nephrectomy for kidney cancer patients
Thursday, 20 December 2012- Urologists at Henry Ford Hospital in the US have developed a new technique that could make minimally invasive robotic partial nephrectomy procedures the norm, rather than the exception for kidney...
Location of distant metastases is a major predictor of cancer-specific survival in kidney cancer patients
Thursday, 29 November 2012- U. Capitanio and colleagues conducted a study to test whether the combination of number and location of distant metastases affects cancer-specific survival in patients with metastatic renal cell...
Combined bisphosphonates with sunitinib linked to better survival of kidney cancer patients with bone metastasis
Tuesday, 20 November 2012- A combined bisphosphonates-sunitinib treatment for kidney cancer patients whose disease have spread to the bones may offer better response and survival rates, according to a joint study by Israeli...













